Labcorp Forms Strategic Partnership With MD Anderson Cancer Center Foundation Spain to Increase Access to Early Phase Oncology Clinical Trials

Labcorp (NYSE: LH), a leading global life sciences company, today announced it has formed a strategic partnership with MD Anderson Cancer Center Foundation Spain, a non-profit organization whose objectives are to beat cancer and to increase accessibility of early phase oncology clinical trials. Through this ...

Related Keywords

Burlington ,Texas ,United States ,Houston ,United Kingdom ,Spain ,Madrid ,Prasanth Reddy ,Enrique Grande ,Md Anderson Madrid Medical Oncology Service ,Linkedin ,Twitter ,Md Anderson Cancer Center Foundation Spain ,Md Anderson Cancer Center ,Md Anderson Foundation Spain ,Labcorp Drug Development ,Cancer Center Foundation Spain ,Madrid Medical Oncology Service ,Anderson Madrid ,Phasei Clinical Trials Unit ,Cancer Center ,Drug Development ,